Clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction: The Gulf-Cardiogenic Shock (G-CS) Registry
Amin Daoulah,Mohammed Alshehri,Prashanth Panduranga,Hatem M Aloui,Nooraldaem Yousif,Abdulrahman Arabi,Wael Almahmeed,Mohammed A Qutub,Ahmed Elmahrouk,Amr A Arafat,Omar Kanbr,Adnan Fathey Hussien,Mubarak Abdulhadi Aldossari,Abdulmohsen H Al Mefarrej,Tarique Shahzad Chachar,Haitham Amin,Gladsy Selva Livingston,Abeer Said Mohamed Al Rawahi,Jassim Alswuaidi,Shahrukh Hashmani,Mohammed Al Jarallah,Mohamed Ajaz Ghani,Badr Alzahrani,Maryam Jameel Naser,Wael Qenawi,Taher Hassan,Abdullah Alenezi,Ahmad S Hersi,Waleed Alharbi,Sultan Al Obaikan,Salman Saad Almalki,Sulafa Almukhtar Mohammed Ballool,Husam A Noor,Manar Khalid AlSuwaidi,Harvey Antony,Marwa Abd Elghany Albasiouny Alkholy,Khaled Alkhodari,Hassan Khan,Ali Alshehri,Ahmed A Ghonim,Seraj Abualnaja,Mokhtar Abdirahman Kahin,Rajesh Rajan,Khaled Almerri,Faisal Omar M Al Nasser,Ahmed Alhaydhal,Mohammed Awad Ashour,Omer A Elamin,Ahmed Jamjoom,Sary Mahmoud Wedinly,Youssef Elmahrouk,Ziad Dahdouh,Ethan M Ross,Said Al Maashani,Abdulwali Abohasan,Wael Tawfik,Mohammed Balghith,Abdelmaksoud Elganady,Ibrahim A M Abdulhabeeb,Rasha Mohammed Borini,Ayman Basardah,Abdulrahman M Alqahtani,Alaa Aldossari,Abdullah Omair Alsuayri,Mushira Khan,Amir Lotfi
DOI: https://doi.org/10.1097/SHK.0000000000002433
2024-08-12
Shock
Abstract:Background: There is a paucity of data regarding acute myocardial infarction (MI) complicated by cardiogenic shock (AMI-CS) in the Gulf region. This study addressed this knowledge gap by examining patients experiencing AMI-CS in the Gulf region and analyzing hospital and short-term follow-up mortality. Methods: The Gulf-CS registry included 1,513 patients with AMI-CS diagnosed between January 2020 and December 2022. Results: The incidence of AMI-CS was 4.1% (1513/37379). The median age was 60 years. The most common presentation was ST-elevation MI (73.83%). In-hospital mortality was 45.5%. Majority of patients were in SCAI stage D and E (68.94%). Factors associated with hospital mortality were previous coronary artery bypass graft (OR:2.49; 95%CI: 1.321-4.693), cerebrovascular accident (OR:1.621, 95%CI: 1.032-2.547), chronic kidney disease (OR:1.572; 95%CI1.158-2.136), non-ST-elevation MI (OR:1.744; 95%CI: 1.058-2.873), cardiac arrest (OR:5.702; 95%CI: 3.640-8.933), SCAI stage D and E (OR:19.146; 95CI%: 9.902-37.017), prolonged QRS (OR:10.012; 95%CI: 1.006-1.019), right ventricular dysfunction (OR:1.679; 95%CI: 1.267-2.226) and ventricular septal rupture (OR:6.008; 95%CI: 2.256-15.998). Forty percent had invasive hemodynamic monitoring, 90.02% underwent revascularization, and 45.80% received mechanical circulatory support (41.31% had Intra-Aortic Balloon Pump and 14.21% had Extracorporeal Membrane Oxygenation/Impella devices). Survival at 12 months was 51.49% (95% CI: 46.44- 56.29%). Conclusions: The study highlighted the significant burden of AMI-CS in this region, with high in-hospital mortality. The study identified several key risk factors associated with increased hospital mortality. Despite the utilization of invasive hemodynamic monitoring, revascularization, and mechanical circulatory support in a substantial proportion of patients, the 12-month survival rate remained relatively low.